List of insiders holdings for SUPERNUS PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | NEA PARTNERS 11 LP 10% Owner |
2015-11-12 15:46:57 | 2,345,864 7,641,250 |
9,987,114 | Form 4 |
| 2 | BARRIS PETER J 10% Owner |
2015-11-12 15:46:03 | 0 6,687,021 |
6,687,021 | Form 4 |
| 3 | SANDELL SCOTT D 10% Owner |
2015-11-12 15:48:44 | 0 6,674,600 |
6,674,600 | Form 4 |
| 4 | BASKETT FOREST 10% Owner |
2015-11-12 15:47:32 | 0 6,663,538 |
6,663,538 | Form 4 |
| 5 | KOLLURI KRISHNA KITTU 10% Owner |
2015-11-12 15:48:02 | 0 6,198,544 |
6,198,544 | Form 4 |
| 6 | Khattar Jack A. President, CEO |
2025-04-03 16:27:28 | 1,025,533 1,022,450 |
2,047,983 | Form 4 |
| 7 | Abingworth Management LTD 10% Owner |
2015-04-21 13:08:33 | 1,459,965 0 |
1,459,965 | Form 13D |
| 8 | ORBIMED ADVISORS LLC ISALY SAMUEL D ORBIMED CAPITAL GP II LLC 10% Owner |
2013-08-20 16:23:47 | 1,122,300 0 |
1,122,300 | Form 13D |
| 9 | SHEFFERY MICHAEL B Director |
2012-05-07 11:44:32 | 0 297,815 |
297,815 | Form 4 |
| 10 | BARRETT M JAMES Director |
2016-03-24 09:01:09 | 97,355 115,355 |
212,710 | Form 4 |
| 11 | NEWHALL CHARLES W III Director |
2025-02-24 17:47:26 | 135,644 0 |
135,644 | Form 4 |
| 12 | Vaughn Victor Sr. VP of Sales & Marketing |
2018-04-20 16:53:07 | 118,994 0 |
118,994 | Form 4 |
| 13 | Pinschewer David Chief Scientific Officer |
2019-04-24 17:33:04 | 116,416 0 |
116,416 | Form 4 |
| 14 | Bryan Jones W. VP of Business Development |
2015-03-31 16:57:24 | 98,743 0 |
98,743 | Form 4 |
| 15 | Martin Tami Tillotson Sr. V.P., Regulatory Affairs |
2024-02-27 17:00:22 | 90,683 0 |
90,683 | Form 4 |
| 16 | SIEBERT JOHN M Director |
2024-02-27 17:02:52 | 87,943 0 |
87,943 | Form 4 |
| 17 | PATRICK GREGORY S Sr. VP Chief Financial Officer |
2020-11-10 16:19:06 | 54,463 0 |
54,463 | Form 4 |
| 18 | Hudson Frederick M. Director |
2025-02-24 17:50:53 | 53,764 0 |
53,764 | Form 4 |
| 19 | Matushansky Igor Chief Medical Officer |
2019-04-24 17:33:04 | 52,064 0 |
52,064 | Form 4 |
| 20 | BIGHAM MICHAEL Director |
2013-03-26 16:33:14 | 8,722 25,000 |
33,722 | Form 4 |
| 21 | Nuerge William A. Director |
2017-06-15 16:42:51 | 29,786 0 |
29,786 | Form 4 |
| 22 | Barlow Carrolee Director |
2025-02-24 17:43:13 | 22,570 0 |
22,570 | Form 4 |
| 23 | GEMAYEL GEORGES Director |
2025-02-24 17:45:13 | 18,684 0 |
18,684 | Form 4 |
| 24 | Mottola Frank SVP, Quality, GMP, Ops, IT |
2025-03-07 16:34:07 | 15,151 0 |
15,151 | Form 4 |
| 25 | Kelly James Patrick Executive Vice-President & CFO |
2021-02-23 18:55:16 | 15,000 0 |
15,000 | Form 4 |
| 26 | Bhatt Padmanabh P. Sr. VP of IP, CSO |
2025-03-05 16:21:18 | 12,704 0 |
12,704 | Form 4 |
| 27 | DEC TIMOTHY C Senior Vice-President & CFO |
2025-03-11 16:15:41 | 12,681 0 |
12,681 | Form 4 |
| 28 | Rubin Jonathan SVP, Chief Medical Officer |
2025-03-05 16:14:47 | 9,635 0 |
9,635 | Form 4 |
| 29 | Lengauer Christoph Director |
2019-04-24 17:32:47 | 6,924 0 |
6,924 | Form 4 |
| 30 | Sensenig Bethany Director |
2025-02-24 17:41:09 | 5,369 0 |
5,369 | Form 4 |
| 31 | Schwabe Stefan K.F. Executive Vice President & CMO |
2020-12-22 17:49:47 | 2,772 0 |
2,772 | Form 4 |
| 32 | NEW ENTERPRISE ASSOCIATES 11 LP NEA PARTNERS 11 LP NEA 11 GP LLC BARRIS PETER J BASKETT FOREST DRANT RYAN D KOLLURI KRISHNA KITTU KRAMLICH C RICHARD PERRY MARK W SANDELL SCOTT D 10% Owner |
2015-12-10 14:05:33 | 0 0 |
0 | Form 13D |
| 33 | NEW ENTERPRISE ASSOCIATES 11 LP 10% Owner |
2015-12-10 14:05:33 | 0 0 |
0 | Form 13D |